GHK-Cu
GHK binds copper and affects signalling associated with skin matrix and repair.
GHK-Cu is a naturally occurring copper complex of glycine-histidine-lysine. Research focuses on extracellular matrix, wound repair and skin biology; evidence for systemic injectable use is far more limited than for topical formulations.
Cosmetic ingredient; injectable claims not established

GHK-Cu is a naturally occurring copper complex of glycine-histidine-lysine. Research focuses on extracellular matrix, wound repair and skin biology; evidence for systemic injectable use is far more limited than for topical formulations.
Research route, formulation and population determine what a result actually means.
GHK binds copper and affects signalling associated with skin matrix and repair.
Studies cell migration, vessel formation and matrix repair in wound models.
Cell, animal and limited topical research. Educational information. Not diagnosis, treatment or use advice.
Small studies and preclinical models suggest effects on matrix remodelling, but formulations and endpoints vary widely.
Topical or animal data cannot be used to predict a systemic dose or efficacy.
Checked identity data for this research compound or blend.
These are compound references, not a batch certificate. Purity and identity of a specific Velora batch must be confirmed by its accompanying COA and laboratory report.
FDA Global Substance Registration System ↗This module only converts concentration and volume. Inputs are not recommendations or individual dosing advice.
Once daily in educational protocols

A visual workflow for controlled laboratory reconstitution. Always follow the product label, COA and a validated protocol.

Disinfect the rubber closures of both vials and allow them to dry.
Withdraw only the diluent validated for the specific compound.
Let the liquid run slowly down the inside wall of the vial.
Do not shake; rotate gently until the material has dissolved.
Follow the product label, COA and validated stability data.
First confirm that the product is a lyophilised vial. Prefilled pens and ready-to-use solutions do not require reconstitution. Check the label, COA and specified diluent.
Wash your hands, clean the work surface and use new sterile equipment for every procedure. Clean both rubber closures with separate alcohol swabs and let them dry completely.
The volume of liquid added changes the concentration in mg per mL, but not the total amount of research compound in the vial. Use the calculator to check this in advance.
Check for unexpected discoloration, cloudiness or visible particles. Record the compound, concentration and reconstitution date. Storage time and temperature are product-specific; a fixed 28-day rule does not apply to every compound.
General examples, not a product-specific protocol. The chosen volume determines concentration; always check the label, COA and calculator.
| Vial strength | Commonly listed volume |
|---|---|
| 2 mg | 1–2 mL |
| 5 mg | 2–3 mL |
| 6 mg | 2–3 mL |
| 10 mg | 2–4 mL |
| 15 mg | 3–5 mL |
| 20 mg | 4–8 mL |
Practical background source: Free Medical Journals — Complete Step-by-Step Guide to Peptide Reconstitution, accessed July 2026. This is a secondary educational source; the product label, COA and validated stability data remain authoritative.
Research route, formulation and population determine what a result actually means.
Educational information. Not diagnosis, treatment or use advice.